Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema

Uyeturk, Ummugul; ÇİNAR ÖZDEMİR, ÖZLEM; Duygu-Yildiz, Elif; Tuğral, Alper; Bakar, Yesim

Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema

Yeşim BAKAR, (School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey)

Alper TUĞRAL, (School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey)

ÖZLEM ÇİNAR ÖZDEMİR, (School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey)

Elif DUYGU, (School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey)

Ümmügül ÜYETÜRK (Department of Medical Oncology, Abant Izzet Baysal University School of Medicine, Bolu, Turkey)

European Journal of Breast Health

7 0

Yıl: 2017 Cilt: 13 Sayı: 3 Sayfa Aralığı: 123 - 128 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema

Öz:

Objective: Breast cancer related lymphedema (BCRL) is a drastic situation that affects patients who have undergone breast cancer surgery. The impact of this condition on individuals’ quality of life should be investigated in more detail to obtain better treatment results. Materials and Methods: In total, 65 patients with BCRL participated in this study. Nottingham Health Profile (NHP) was used to evaluate the validity of associated domains in Lymphedema Quality of Life Tool (LYMQoL). Both the LYMQoL and NHP were filled out by BCRL patients. To evaluate its test-retest reliability, the LYMQoL was subsequently performed seven days following its initial application. Measurement properties such as internal consistency, test-retest reliability, criterion validity and factor structure were tested. The internal consistency was assessed via Cronbach’s alpha; test-retest reliability was assessed by the intra-class correlation coefficient (ICC).Results: Cronbach’s alpha values ranged from 0.74 to 0.91 for the LYMQoL total and domain scores. Test-retest reliability was excellent (ICC=0.92-0.99). When the relation between LYMQoL and NHP was investigated, ‘good’ to ‘very good’ correlations were obtained (r=0.5390.643, p<0.05) for all domains of LYMQoL. Exploratory factor analyses demonstrated a four-factor structure. Conclusion: Turkish version of LYMQoL is a valid and reliable measurement tool to evaluate the quality of life in patients with BCRL

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Gultekin M, Boztas G. Türkiye kanser istatistikleri. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu (Turkish Only). 2014; 43.
2. Kibar S, Dalyan Aras M, Ünsal Delialioglu S. The risk factors and prevalence of upper extremity impairments and an analysis of effects of lymphoedema and other impairments on the quality of life of breast cancer patients. Eur J Cancer 2016; 13.
3. Thomas-MacLean R, Miedema B, Tatemichi SR. Breast cancer-related lymphedema: women’s experiences with an underestimated condition. Can Fam Physician 2005; 51: 246-247. (PMID:16926934)
4. Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2007; 16: 775-782. (PMID:17416770) [CrossRef]
5. Bakar Y, Berdici B, Sahin N, Pala OO. Lymphedema after Breast Cancer and its Treatment. Eur J Breast Health 2014; 10: 6-14. [CrossRef]
6. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013; 14: 500-515. [CrossRef]
7. Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Ung OA, Dylke ES, French JR, Yee J, Koelmeyer L, Gaitatzis K. Risk factors for lymphoedema in women with breast cancer: A large prospective cohort. The Breast 2016; 28: 29-36. (PMID:27183497) [CrossRef]
8. Shi S, Lu Q, Fu MR, Ouyang Q, Liu C, Lv J, Wang Y. Psychometric properties of the breast cancer and lymphedema symptom experience index: the Chinese version. Eur J Oncol Nurs 2016; 20: 10-16. (PMID:26071198) [CrossRef]
9. Smoot B, Wong J, Cooper B, Wanek L, Topp K, Byl N, Dodd M. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv 2010; 4: 167-178. (PMID:20373044) [CrossRef]
10. Keeley V, Crooks S, Locke J, Veigas D, Riches K, Hilliam R. A quality of life measure for limb lymphoedema (LYMQOL). J Lymphoedema 2010; 5: 26-37.
11. van de Pas CB, Biemans AA, Boonen RS, Viehoff PB, Neumann HA. Validation of the Lymphoedema Quality-of-Life Questionnaire (LYMQOL) in Dutch Patients Diagnosed with Lymphoedema of the Lower Limbs. Phlebology 2016; 31: 257-263. (PMID:25956549) [CrossRef]
12. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000; 25: 3186-3191. (PMID:11124735) [CrossRef]
13. Kücükdeveci A, McKenna S, Kutlay S, Gürsel Y, Whalley D, Arasil T. The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 2000; 23: 31-38. (PMID:10826123) [CrossRef]
14. Bhatnagar R, Kim J, Many JE. Candidate surveys on program evaluation: Examining Instrument reliability, validity and program effectiveness. Am J Educ Res 2014; 2: 683-690. [CrossRef]
15. Shamliyan T, Kane RL, Dickinson S. A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. J Clin Epidemiol 2010; 63: 1061- 1070. (PMID:20728045) [CrossRef]
16. Feise RJ, Menke JM. Functional rating index: a new valid and reliable instrument to measure the magnitude of clinical change in spinal conditions. Spine 2001; 26: 78-87. [CrossRef]
17. Hooper D. Exploratory factor analysis.Approaches to Quantitative Research -Theory and its Practical Application: A Guide to Dissertation Students, Cork, Ireland. Oak Tree Press 2012.p.1-32.
18. Osborne JW, Costello AB. Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. Pan-Pac Manage Rev 2009; 12: 131-146.
19. Ridner SH, Bonner CM, Deng J, Sinclair VG. Voices from the shadows: living with lymphedema. Cancer Nurs 2012; 35: E18. (PMID:21558848) [CrossRef]
20. Fayers PM, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2nd ed. Sussex, England. John Wiley & Sons; 2013.
21. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg 1999; 177: 184-188. [CrossRef]
22. Ridner SH, Dietrich MS, Kidd N. Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life. Support Care Cancer 2011; 19: 631-637. (PMID:20393753) [CrossRef]
23. Morgan PA, Franks PJ, Moffatt CJ. Health‐related quality of life with lymphoedema: a review of the literature. Int Wound J 2005; 2: 47-62. (PMID:16722853) [CrossRef]
24. Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol 2003; 56: 730-735. [CrossRef]
25. Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens M-R. Lymphoedema Functioning, Disability and Health questionnaire (Lymph-ICF): reliability and validity. Phys Ther 2011; 91: 944-957. (PMID:21493748) [CrossRef]
26. Patel KM, Cheng M-H. A prospective evaluation of lymphedema-specific quality of life outcomes following vascularized lymph node transfer. Ann Surg Oncol 2015; 22: 2424-2430. (PMID:25515196) [CrossRef]
27. Iuchi T, Dai M, Sanada H, Okuwa M, Nakatani T, Sugama J. Associations between the treatments and outcomes of patients with upper and lower lymphoedema in Japan: A cross-sectional observational study. Int J Nurs Stud 2015; 52: 913-919. (PMID:25769476) [CrossRef]
28. Mirolo BR, Bunce IH, Chapman M, Olsen T, Eliadis P, Hennessy JM, Ward LC, Jones LC. Psychosocial benefits of postmastectomy lymphedema therapy. Cancer Nurs 1995; 18: 197-205. (PMID:7600551) [CrossRef ]
29. Viehoff P, van Genderen F, Wittink H. Upper limb lymphedema 27 (ULL27): Dutch translation and validation of an illness-specific healthrelated quality of life questionnaire for patients with upper limb lymphedema. Lymphology 2008; 41: 131-138. (PMID:19013881)
30. Kostanoglu A, Hosbay Z, Tarakci E. Lymphoedema functioning, disability and health questionnaire Turkish version: translation, cross-cultural adaptation and validation. J Phys Ther Sci 2016; 28: 1728-1732. (PMID:27390404) [CrossRef]

APA	Bakar Y, Tuğral A, ÇİNAR ÖZDEMİR Ö, Duygu-Yildiz E, Uyeturk U (2017). Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. , 123 - 128.
Chicago	Bakar Yesim,Tuğral Alper,ÇİNAR ÖZDEMİR ÖZLEM,Duygu-Yildiz Elif,Uyeturk Ummugul Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. (2017): 123 - 128.
MLA	Bakar Yesim,Tuğral Alper,ÇİNAR ÖZDEMİR ÖZLEM,Duygu-Yildiz Elif,Uyeturk Ummugul Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. , 2017, ss.123 - 128.
AMA	Bakar Y,Tuğral A,ÇİNAR ÖZDEMİR Ö,Duygu-Yildiz E,Uyeturk U Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. . 2017; 123 - 128.
Vancouver	Bakar Y,Tuğral A,ÇİNAR ÖZDEMİR Ö,Duygu-Yildiz E,Uyeturk U Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. . 2017; 123 - 128.
IEEE	Bakar Y,Tuğral A,ÇİNAR ÖZDEMİR Ö,Duygu-Yildiz E,Uyeturk U "Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema." , ss.123 - 128, 2017.
ISNAD	Bakar, Yesim vd. "Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema". (2017), 123-128.

APA	Bakar Y, Tuğral A, ÇİNAR ÖZDEMİR Ö, Duygu-Yildiz E, Uyeturk U (2017). Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. European Journal of Breast Health, 13(3), 123 - 128.
Chicago	Bakar Yesim,Tuğral Alper,ÇİNAR ÖZDEMİR ÖZLEM,Duygu-Yildiz Elif,Uyeturk Ummugul Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. European Journal of Breast Health 13, no.3 (2017): 123 - 128.
MLA	Bakar Yesim,Tuğral Alper,ÇİNAR ÖZDEMİR ÖZLEM,Duygu-Yildiz Elif,Uyeturk Ummugul Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. European Journal of Breast Health, vol.13, no.3, 2017, ss.123 - 128.
AMA	Bakar Y,Tuğral A,ÇİNAR ÖZDEMİR Ö,Duygu-Yildiz E,Uyeturk U Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. European Journal of Breast Health. 2017; 13(3): 123 - 128.
Vancouver	Bakar Y,Tuğral A,ÇİNAR ÖZDEMİR Ö,Duygu-Yildiz E,Uyeturk U Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema. European Journal of Breast Health. 2017; 13(3): 123 - 128.
IEEE	Bakar Y,Tuğral A,ÇİNAR ÖZDEMİR Ö,Duygu-Yildiz E,Uyeturk U "Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema." European Journal of Breast Health, 13, ss.123 - 128, 2017.
ISNAD	Bakar, Yesim vd. "Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema". European Journal of Breast Health 13/3 (2017), 123-128.